CBD Life Sciences Inc. (CBDL) CEO Lisa Nelson Interviews With The Morning Show
Rhea-AI Summary
CBD Life Sciences (OTC:CBDL) CEO Lisa Nelson appeared on The Morning Show on December 2, 2025 to discuss the company's rapid expansion across multiple wellness verticals. Highlights include category expansion into topicals, edibles, functional water, nutraceutical powders and veterinarian products, plus a Walmart Marketplace approval for the 3000mg Pain Cream. The release cites a $14.6B 2025 CBD market value and a projection to $203.4B by 2034. Management points to four‑digit year‑over‑year revenue growth since early 2024 and retail, spa, and e‑commerce distribution efforts as drivers of near‑term scaling potential.
Positive
- Global CBD market projected at $203.4B by 2034
- Market valued at $14.6B in 2025
- Walmart Marketplace approval for 3000mg Pain Cream
- Reported four‑digit year‑over‑year revenue growth since early 2024
Negative
- None.
News Market Reaction
On the day this news was published, CBDL declined NaN%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
CBDL traded flat while peers were mixed: PLSH -31.58%, KOAN -10.14%, with HEMP, OVATF, and CANB unchanged. The lack of broad upside and absence of momentum scanner hits suggests this interview-driven story was stock-specific rather than part of a sector-wide CBD rally.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 02 | CEO media interview | Positive | +0.0% | CEO outlined rapid expansion, Walmart approval, and high CBD market growth. |
| Nov 18 | Product launch | Positive | -33.3% | Launch of Anti-Inflammatory Soothe Gel across two Red Hots Spa locations. |
| Nov 12 | Wholesale order | Positive | +0.0% | Repeat hemp flower order plus cited 1405.46% revenue increase and NY expansion. |
| Oct 28 | New gummies launch | Positive | -33.3% | Launch of hemp-free Energy and Diet Gummies targeting large supplements market. |
| Oct 21 | Mushroom chocolate launch | Positive | +33.3% | Mushroom-infused Dubai Chocolate Bar tied to fast-growing functional markets. |
Positive product and expansion news has often been met with flat or negative next-day moves, with only one of five recent upbeat releases showing a positive price reaction.
This announcement continues a string of CBDL growth narratives over the last few months. In October–November 2025, the company highlighted new SKUs such as hemp-free Energy and Diet Gummies, a mushroom-infused Dubai chocolate bar, and the Soothe Gel rollout into Red Hots Spa locations. Prior releases cited a 1405.46% revenue increase since February 2024 and large addressable markets, including a projected $7.2B New York cannabis market and a global functional mushroom market of $35B by 2030. The current interview ties these product and distribution steps into a broader multi-vertical wellness strategy.
Market Pulse Summary
This announcement frames CBDL as an emerging multi-vertical wellness brand, tying a Morning Show CEO interview to themes of product expansion, Walmart Marketplace approval, and four-digit revenue growth since early 2024. It also cites a CBD market expected to grow from $14.6B in 2025 to $203.4B by 2034 at a 34%+ CAGR. Investors monitoring this story may focus on concrete revenue disclosures, additional retail placements, and evidence that these strategic initiatives sustain reorder rates and margin expansion.
Key Terms
compound annual growth rate financial
nutraceutical medical
micro-cap financial
AI-generated analysis. Not financial advice.
"Inside the explosive rise of a wellness company outpacing a
Watch the full Morning Show interview →
SCOTTSDALE, ARIZONA / ACCESS Newswire / December 2, 2025 / CBD Life Sciences Inc. (OTCID:CBDL) is gaining powerful investor momentum this week following a spotlight interview with CEO Lisa Nelson on The Morning Show. Nelson discussed CBDL's rapid expansion, new retail partnerships, rising demand for its flagship therapeutic products, and the company's long-term vision as it positions itself inside one of the fastest-growing wellness markets in the world.
This high-visibility interview arrives during a period of acceleration for CBDL, as the company continues strengthening product distribution, manufacturing capabilities, and strategic alignments across multiple billion-dollar verticals - including therapeutic topicals, edibles, alkaline CBD functional water, veterinarian-developed animal wellness products, and advanced nutraceutical powders.
A Market Quietly Evolving Into a
The CBD industry is experiencing a transformation few investors anticipated just a few years ago.
Industry research shows:
The global CBD market was valued at
$14.6 billion in 2025, projected to rocket to$203.4 billion by 2034, representing an extraordinary34% + compound annual growth rate.CBD topicals, ingestibles, functional beverages, and pet wellness products are among the fastest-growing categories in health and consumer goods.
Retail and e-commerce distribution continues expanding as CBD transitions from niche product to mainstream wellness staple.
Against this backdrop, CBDL's aggressive multi-sector strategy places it in a uniquely favorable position to capture early-stage market share before full institutional saturation occurs.
Lisa Nelson: "Our mission isn't just to exist within this industry - it's to lead it through innovation, transparency, and results."
During her interview, Nelson highlighted CBDL's expanding ecosystem of high-demand CBD wellness products and the company's commitment to premium, performance-driven formulations.
1. Category Expansion Across High-Demand Wellness Sectors
CBDL continues to broaden its footprint across lucrative verticals, including:
Topicals: 3000mg Pain Relief Cream (now approved on Walmart Marketplace), Anti-Inflammatory Soothe Gel formulated for luxury spa partners
Edibles: Gummies, lozenges, and therapeutic ingestibles with strong consumer reorder rates
Functional Water: Alkaline CBD hydration products
Nutraceutical Powders: Reishi, lion's mane, and ashwagandha blends designed for stress relief, cognitive support, and inflammation reduction
Veterinarian Wellness: CBD horse paste and pet-focused formulations designed to support mobility, recovery, and behavioral calm
Each of these categories independently represents annual markets measured in billions - and CBDL is entering all of them with proprietary formulas and growing distribution.
2. Strengthening Retail Distribution Channels
CBDL's retail expansion continues to build momentum, with recent accomplishments including:
Walmart Marketplace approval for its best-selling 3000mg Pain Cream
Ongoing distribution through luxury spa chains such as Red Hots Spa at Garden City Hotel and Roslyn, NY
Active retail expansion strategies targeting multi-state wellness operators, boutique spas, and functional retail chains
3. Manufacturing Strength, Quality Control & Innovation
Nelson emphasized CBDL's commitment to scientifically backed formulations and manufacturing excellence, highlighting that:
"Consumers trust results. That's why we invest heavily in formulation quality and internal controls. It's the foundation of our brand - and our growth."
A Revenue Growth Story That Signals Early Momentum
Unlike many emerging wellness companies that face scaling challenges, CBDL is demonstrating real revenue traction, supported by:
Four-digit year-over-year revenue growth since early 2024
High reorder frequency from luxury spa partners and retail buyers
Early-stage wholesale traction from multi-unit retailers
Expanded margins due to vertically coordinated sourcing and manufacturing efficiencies
For a micro-cap, these are significant performance indicators - and they serve as early signals of a company moving into its next growth phase.
Positioned for 2025-2027: The Years That Could Define CBDL's Market Share
Industry experts forecast that the next two to three years will shape the long-term winners in the CBD wellness space. Key drivers include:
Clearer regulatory environments
Rising mainstream consumer adoption
Surge in demand for natural pain-relief solutions
Increased interest in plant-based, non-pharmaceutical wellness
E-commerce and marketplace expansion at scale
CBDL is preparing to capitalize on this shift through:
New therapeutic topical launches
Expanded pet and equine wellness lines
Enhanced Amazon and Walmart catalog strategies
Strategic B2B partnerships across fitness, spa, and hospitality channels
Increased manufacturing capacity and R&D investment
If executed effectively, CBDL has the potential to transition from a regional wellness brand into a national multi-vertical category competitor.
Why Investors Are Watching CBDL Closely
CBD Life Sciences Inc. offers investors a compelling combination of:
Product diversification across multiple high-growth categories
Strengthened retail reach through major online marketplaces and luxury spa partners
Leadership with credibility, vision, and public-facing communication strength
Real revenue traction, not hypothetical growth
A micro-cap valuation primed for expansion, offering potentially asymmetric upside
When matched with the projected
Final Takeaway: CBDL Is Entering Its Momentum Phase
Lisa Nelson's interview on The Morning Show represents more than media coverage - it marks a shift into mainstream visibility and signals the acceleration of strategic milestones already underway.
CBDL is building real momentum, real traction, and real investor appeal at the perfect intersection of market timing and product expansion.
As the CBD sector continues to evolve at record pace, CBDL stands positioned as a brand with:
A disciplined growth strategy
Strong leadership
Expanding product lines
Deep market potential
And the kind of early-stage trajectory investors seek before major scaling events
The next 12-36 months could define the company's long-term market position - and early investors are paying close attention.
About CBD Life Sciences Inc. (CBDL)
CBD Life Sciences Inc. is a publicly traded company focused on developing and distributing high-quality CBD and wellness products through its flagship brand, The CBD Vault. With an expanding portfolio of therapeutic formulations, the company is aggressively scaling into retail, wholesale, and online sales channels nationwide.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
Website: https://www.thecbdvault.com
IR Contact: cbdvaultaz@gmail.com
Stay Connected & Be the First to Try Our New Functional Mushroom Products!
Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720
SOURCE: CBD Life Sciences, Inc.
View the original press release on ACCESS Newswire
FAQ
What did CBD Life Sciences (CBDL) announce on December 2, 2025?
Does CBDL have retail distribution with major marketplaces?
What market size figures were cited for the CBD industry in the announcement?
What revenue momentum did CBDL report for investors?
Which product categories is CBDL expanding into and why does it matter for shareholders?
How could CBDL position itself from 2025–2027 according to the company?
